Company: BIVIW
Filing Date: 2025-07-22
Form Type: S-1/A
Source: 0001520138-25-000216
Chunk: 191

Company: BIOVIE INC.
Filing Date: 2025-07-22
Form: S-1/A
Chunk 191
---
                                                                                                                             |     |           |    2,842,270 |   |     |          |    9,702,130 |   |
| Commitments and contingencies (Note 10)                                                                                                                                                                                                                                       |     |           |              |   |     |          |              |   |
| STOCKHOLDERS' EQUITY:                                                                                                                                                                                                                                                         |     |           |              |   |     |          |              |   |
| Preferred stock; $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding                                                                                                                                                                              |     |           |            - |   |     |          |            - |   |
| Common stock, $0.0001 par value; 800,000,000 shares authorized at March 31, 2025 and June 30, 2024; 18,545,735 shares issued of which 18,517,376 shares are outstanding at March 31, 2025; and 6,216,398 shares issued of which 6,190,072 shares outstanding at June 30, 2024 |     |           |        7,463 |   |     |          |        6,229 |   |
| Additional paid in capital                                                                                                                                                                                                                                                    |     |           |  370,465,616 |   |     |          |  349,732,674 |   |
| Accumulated deficit                                                                                                                                                                                                                                                           |     |           | (348,655,105 | ) |     |          | (334,232,661 | ) |
| Treasury stock                                                                                                                                                                                                                                                                |     |           |          (29 | ) |     |          |          (27 | ) |
| Total stockholders' equity                                                                                                                                                                                                                                                    |     |           |   21,817,945 |   |     |          |   15,506,215 |   |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                                                                                                                                                                                                                    |     | $         |   24,660,215 |   |     | $        |   25,208,345 |   |

<div align='center'>See accompanying notes to unaudited condensed financial
statements

F-26

BioVie Inc.

Condensed Statements of Operations and Comprehensive Loss

(Unaudited)</div>

|                                                                                        |     | Three Months Ended | March 31, 2025 |   |     | Three Months Ended | March 31, 202